DHR vs HQY
Danaher Corporation vs HealthEquity — AI-powered side-by-side comparison
DHR
Danaher Corporation
63
Buy
VS
| Metric | DHR | HQY |
|---|
| AI Score |
63
|
64
|
| Price |
$209.32
|
$106.83
|
| P/E Ratio |
36.24×
|
38.75×
|
| ROE |
6.9%
|
10.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
58.5%
|
72.7%
|
| Debt / Equity |
0.51×
|
0.48×
|
| Dividend Yield |
0.7%
|
0.0%
|
| RSI (14) |
67.2
|
65.8
|
| Beta |
0.796
|
0.21
|
| Expected Upside |
+1.6%
|
+1.0%
|
AI Committee View
Current Innellis committee reasoning for DHR versus HQY.
HQY leads by 1 points.
HQY scores 64/100 (Buy) versus DHR at 63/100 (Buy).
DHR Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.40 across 26 articles, 14d). The main limiting factor is p/e of 36.2 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 36.2 is moderate-to-rich — Value
HQY Committee View
80% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 4 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 15.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Weekly RSI at 76 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 15.3% signals elevated volatility — Risk